MACERICH CO (MAC) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.22%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.22% | Share-based compensation / revenue. Period ending 2026-06-30. $22.30M ÷ $1.01B × 100 ≈ 2.22% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 1.01B USD | |
| Stock-based compensation | 22.30M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.01B | $22.30M | (m) | (m) | (m) | 2.22% | (m) | (m) |
| 2026-03-31 | (m) | $1.01B | $20.86M | (m) | (m) | (m) | 2.07% | (m) | (m) |
| 2025-12-31 | (m) | $1.01B | $18.17M | (m) | (m) | (m) | 1.79% | (m) | (m) |
| 2025-09-30 | (m) | $1.03B | $16.84M | (m) | (m) | (m) | 1.64% | (m) | (m) |
| 2025-06-30 | (m) | $992.92M | $15.45M | (m) | (m) | (m) | 1.56% | (m) | (m) |
| 2025-03-31 | (m) | $958.64M | $12.61M | (m) | (m) | (m) | 1.32% | (m) | (m) |
| 2024-12-31 | (m) | $918.20M | $12.13M | (m) | (m) | (m) | 1.32% | (m) | (m) |
| 2024-09-30 | (m) | $883.22M | $10.90M | (m) | (m) | (m) | 1.23% | (m) | (m) |
| 2024-06-30 | (m) | $881.14M | $8.49M | (m) | (m) | (m) | 0.96% | (m) | (m) |
| 2024-03-31 | (m) | $878.00M | $11.00M | (m) | (m) | (m) | 1.25% | (m) | (m) |
| 2023-12-31 | (m) | $884.07M | $13.17M | (m) | (m) | (m) | 1.49% | (m) | (m) |
| 2023-09-30 | (m) | $873.61M | $15.10M | (m) | (m) | (m) | 1.73% | (m) | (m) |
| 2023-06-30 | (m) | $866.16M | $18.35M | (m) | (m) | (m) | 2.12% | (m) | (m) |
| 2023-03-31 | (m) | $857.87M | $17.66M | (m) | $204.41M | (m) | 2.06% | (m) | Reported |
| 2022-12-31 | (m) | $859.16M | $17.64M | (m) | $216.85M | (m) | 2.05% | (m) | Reported |
| 2022-09-30 | (m) | $860.34M | $16.82M | (m) | $201.21M | (m) | 1.96% | (m) | Reported |
| 2022-06-30 | (m) | $861.77M | $15.96M | (m) | $188.92M | (m) | 1.85% | (m) | Reported |
| 2022-03-31 | (m) | $873.16M | $15.11M | (m) | $190.64M | (m) | 1.73% | (m) | Reported |
| 2021-12-31 | (m) | $847.44M | $14.27M | (m) | $192.68M | (m) | 1.68% | (m) | Reported |
| 2021-09-30 | (m) | $812.68M | $13.72M | (m) | $159.40M | (m) | 1.69% | (m) | Reported |
| 2021-06-30 | (m) | $786.38M | $13.81M | (m) | $156.25M | (m) | 1.76% | (m) | Reported |
| 2021-03-31 | (m) | $749.50M | $13.65M | (m) | $121.37M | (m) | 1.82% | (m) | Reported |
| 2020-12-31 | (m) | $786.03M | $13.84M | (m) | $75.55M | (m) | 1.76% | (m) | Reported |
| 2020-09-30 | (m) | $833.22M | $13.27M | (m) | $113.28M | (m) | 1.59% | (m) | Reported |
| 2020-06-30 | (m) | $878.51M | $12.09M | (m) | $90.90M | (m) | 1.38% | (m) | Reported |
| 2020-03-31 | (m) | $927.89M | $10.74M | (m) | $107.97M | (m) | 1.16% | (m) | Reported |
| 2019-12-31 | (m) | $927.46M | $12.03M | (m) | $138.25M | (m) | 1.30% | (m) | Reported |
| 2019-09-30 | (m) | $932.50M | $14.48M | (m) | $136.75M | (m) | 1.55% | (m) | Reported |
| 2019-06-30 | (m) | $943.57M | $15.71M | (m) | $166.88M | (m) | 1.66% | (m) | Reported |
| 2019-03-31 | (m) | $950.14M | $21.88M | (m) | $168.68M | (m) | 2.30% | (m) | Reported |
| 2018-12-31 | (m) | $960.35M | $27.37M | (m) | $182.96M | (m) | 2.85% | (m) | Reported |
| 2018-09-30 | (m) | $970.22M | $28.28M | (m) | $181.37M | (m) | 2.92% | (m) | Reported |
| 2018-06-30 | (m) | $970.47M | $30.24M | (m) | $179.70M | (m) | 3.12% | (m) | Reported |
| 2018-03-31 | (m) | $983.35M | $28.00M | (m) | $183.11M | (m) | 2.85% | (m) | Reported |
| 2017-12-31 | (m) | $993.66M | $30.80M | (m) | $171.78M | (m) | 3.10% | (m) | Reported |
| 2017-09-30 | (m) | $1.01B | $30.80M | (m) | $169.61M | (m) | 3.05% | (m) | Reported |
| 2017-06-30 | (m) | $1.02B | $30.93M | (m) | $166.33M | (m) | 3.03% | (m) | Reported |
| 2017-03-31 | (m) | $1.03B | $30.65M | (m) | $165.20M | (m) | 2.97% | (m) | Reported |
| 2016-12-31 | (m) | $1.04B | $33.29M | (m) | $163.68M | (m) | 3.20% | (m) | Reported |
| 2016-09-30 | (m) | $1.09B | $32.38M | (m) | $169.76M | (m) | 2.97% | (m) | Reported |
| 2016-06-30 | (m) | $1.16B | $31.17M | (m) | $184.73M | (m) | 2.68% | (m) | Reported |
| 2016-03-31 | (m) | $1.23B | $30.34M | (m) | $198.43M | (m) | 2.48% | (m) | Reported |
| 2015-12-31 | (m) | $1.29B | $28.37M | (m) | $211.94M | (m) | 2.20% | (m) | Reported |
| 2015-09-30 | (m) | $1.29B | $27.88M | (m) | $213.89M | (m) | 2.16% | (m) | Reported |
| 2015-06-30 | (m) | $1.23B | $27.83M | (m) | $206.73M | (m) | 2.27% | (m) | Reported |
| 2015-03-31 | (m) | $1.16B | $27.43M | (m) | $197.64M | (m) | 2.37% | (m) | Reported |
| 2014-12-31 | (m) | $1.11B | $29.46M | (m) | $190.69M | (m) | 2.67% | (m) | Reported |
| 2014-09-30 | (m) | $1.06B | $35.51M | (m) | $187.53M | (m) | 3.34% | (m) | Reported |
| 2014-06-30 | (m) | $1.06B | $36.27M | (m) | $189.33M | (m) | 3.42% | (m) | Reported |
| 2014-03-31 | (m) | $1.05B | $37.01M | (m) | $193.91M | (m) | 3.52% | (m) | Reported |
| 2013-12-31 | (m) | $1.03B | $24.21M | (m) | $197.25M | (m) | 2.35% | (m) | Reported |
| 2013-09-30 | (m) | $1.06B | $17.29M | (m) | $210.20M | (m) | 1.63% | (m) | Reported |
| 2013-06-30 | (m) | $998.54M | $15.59M | (m) | $199.10M | (m) | 1.56% | (m) | Reported |
| 2013-03-31 | (m) | $934.16M | $13.23M | (m) | $187.95M | (m) | 1.42% | (m) | Reported |
| 2012-12-31 | (m) | $881.32M | $12.32M | (m) | $176.78M | (m) | 1.40% | (m) | Reported |
| 2012-09-30 | (m) | $866.51M | $11.81M | (m) | $187.30M | (m) | 1.36% | (m) | Reported |
| 2012-06-30 | (m) | $844.16M | $11.22M | (m) | $188.44M | (m) | 1.33% | (m) | Reported |
| 2012-03-31 | (m) | $820.71M | $12.71M | (m) | $189.68M | (m) | 1.55% | (m) | Reported |
| 2011-12-31 | (m) | $791.25M | $12.29M | (m) | $195.28M | (m) | 1.55% | (m) | Reported |
| 2011-09-30 | (m) | $786.59M | $13.06M | (m) | $203.69M | (m) | 1.66% | (m) | Reported |
| 2011-06-30 | (m) | $776.87M | $14.44M | (m) | $206.20M | (m) | 1.86% | (m) | Reported |
| 2011-03-31 | (m) | $767.51M | $14.40M | (m) | $209.40M | (m) | 1.88% | (m) | Reported |
| 2010-12-31 | (m) | $758.56M | $14.83M | (m) | $212.82M | (m) | 1.96% | (m) | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $805.65M | $8.10M | (m) | $267.05M | (m) | 1.00% | (m) | Reported |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $880.87M | $11.65M | (m) | $295.07M | (m) | 1.32% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VORNADO REALTY TRUST (VNO) | United States | $6.419B | 108.15 |
| Healthcare Realty Trust Inc (HR) | United States | $6.107B | -79.57 |
| RAYONIER INC (RYN) | United States | $5.734B | 13.37 |
| ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT) | United States | $5.727B | 24.06 |
| STAG Industrial, Inc. (STAG) | United States | $7.131B | 28.24 |
| STARWOOD PROPERTY TRUST, INC. (STWD) | United States | $5.312B | 22.96 |
| Ryman Hospitality Properties, Inc. (RHP) | United States | $7.701B | 29.86 |
| Rithm Capital Corp. (RITM) | United States | $5.093B | 10.56 |
| Sabra Health Care REIT, Inc. (SBRA) | United States | $5.053B | 76.12 |
| KITE REALTY GROUP TRUST (KRG) | United States | $4.949B | 16.44 |